Clinical Characteristics and Outcomes of 1894 Women with Peripartum Cardiomyopathy Treated with and Without Levosimendan in Germany
PPCM is a rare disease in Germany with a prevalence of 0.01%. Despite higher complication rates in women with levosimendan treatment, further studies are necessary to help determine the role and timing of levosimendan in the treatment of women with PPCM.
Authors
- Benjamin Friedrichson (ORCID: https://orcid.org/0000-0003-3790-281X)
- Kai Zacharowski (ORCID: https://orcid.org/0000-0002-0212-9110)
- Vanessa Neef (ORCID: https://orcid.org/0000-0002-1793-2918)
- Stephanie Noone (ORCID: https://orcid.org/0000-0002-6755-0539)
- Armin Niklas Flinspach (ORCID: https://orcid.org/0000-0003-2886-8947)
- Jan Andreas Kloka (ORCID: https://orcid.org/0000-0001-6890-3239)
- Thomas Jasny (ORCID: https://orcid.org/0009-0008-5845-6015)
- Peter Kranke
- Lea V. Blum
- Alexandra Popescu
Institutions
- Goethe University Frankfurt (DE)
- Universitätsklinikum Würzburg (DE)
- University Hospital Frankfurt (DE)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2026-03-09
- DOI
- https://doi.org/10.3390/jcdd13030126
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00